SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-148077
Filing Date
2024-05-28
Accepted
2024-05-28 16:01:04
Documents
16
Period of Report
2024-05-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d811339d8k.htm   iXBRL 8-K 29338
2 EX-1.1 d811339dex11.htm EX-1.1 175001
3 EX-5.1 d811339dex51.htm EX-5.1 8369
7 GRAPHIC g811339dsp46.jpg GRAPHIC 4043
  Complete submission text file 0001193125-24-148077.txt   391071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cytk-20240528.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cytk-20240528_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cytk-20240528_pre.xml EX-101.PRE 10815
20 EXTRACTED XBRL INSTANCE DOCUMENT d811339d8k_htm.xml XML 3533
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 24991585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)